The »Furberg bias« - Or: About the arbitrary handling of the evidence-based medicine;»Furberg-bias« - Oder: Vom beliebigen umgang mit evidence-based medicine

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 6, 2001, Pages 151-152

  Middeke, M ^a  

^a DMW Chefredaktion   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CLINICAL RESEARCH; ENZYME INHIBITION; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; NOTE; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; META ANALYSIS; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; META-ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035830481     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-11045     Document Type: Note

References (13)

1. Evidence-Based Medicine, forschungstransfer und die rolle der medizinischen journale
2. Kalziumantagonisten näher betrachtet
3. Rationale and design for the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial
4. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
5. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): A randomized controlled trial
6. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL)
7. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
8. Nifedipine - Dose-related increase in mortality in patients with coronary artery disease
9. Wirkung von felodipin bei hypertonen patienten mit leichten hirnleistungsstörungen in einer randomisiert doppelblindstudie
10. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomiesd controlled trials
11. »Evidence-biased medicine« - Oder: Die trügerische sicherheit der evidenz
12. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial in patients with hypertension and NIDDM
13. Kognitive störungen und demenz - Neue endorganschäden bei hypertonie